McCune-Albright syndrome and acromegaly: Effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 12, 2006, Pages 4957-4961

  Galland, Françoise ^a   Kamenicky, Peter ^a,d   Affres, Hélène ^a   Reznik, Yves ^b   Pontvert, Dominique ^c   Le Bouc, Yves ^e   Young, Jacques ^a,d,f   Chanson, Philippe ^a,d,f  

^a BICÊTRE HOSPITAL   (France)

^b CHU CÔTE DE NACRE   (France)

^c INSTITUT CURIE   (France)

^d INSERM   (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; GROWTH HORMONE; OCTREOTIDE; ORAL ANTIDIABETIC AGENT; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ACROMEGALY; ADULT; ALBRIGHT SYNDROME; ARTICLE; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG WITHDRAWAL; FEMALE; GLUCOSE INTOLERANCE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 33845473676     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0561     Document Type: Article

References (20)

1. Weinstein LS, Yu S, Warner DR, Liu J 2001 Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr Rev 22:675-705
2. Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT 2002 Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104-5112
3. Chanson P, Dib A, Visot A, Derome PJ 1994 McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol 131:229-234
4. Mock D, Rosen IB 1986 Osteosarcoma in irradiated fibrous dysplasia. J Oral Pathol 15:1-4
5. Mortensen A, Bojsen-Moller M, Rasmussen P 1989 Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation. Two cases with a review of the literature. J Neurooncol 7:25-29
6. Ruggieri P, Sim FH, Bond JR, Unni KK 1994 Malignancies in fibrous dysplasia. Cancer 73:1411-1424
7. Hansen MR, Moffat JC 2003 Osteosarcoma of the skull base after radiation therapy in a patient with McCune-Albright syndrome: case report. Skull Base 13:79-83
8. Cuttler L, Jackson JA, Saeed uz-Zafar M, Levitsky LL, Mellinger RC, Frohman LA 1989 Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 68:1148-1154
9. Geffner ME, Nagel RA, Dietrich RB, Kaplan SA 1987 Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J Pediatr 111:740-743
10. Cremonini N, Graziano E, Chiarini V, Sforza A, Zampa GA 1992 Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Clin Endocrinol Metab 75:1166-1169
11. Feuillan PP, Jones J, Ross JL 1995 Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 80:1357-1360
12. Ducos B, Cabrol S, Houang M, Perin L, Holzenberger M, Le Bouc Y 2001 IGF type 1 receptor ligand binding characteristics are altered in a subgroup of children with intrauterine growth retardation. J Clin Endocrinol Metab 86:5516-5524
13. Hall EJ, Wuu CS 2003 Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56:83-88
14. Huvos AG, Higinbotham NL, Miller TR 1972 Bone sarcomas arising in fibrous dysplasia. J Bone Joint Surg Am 54:1047-1056
15. Present D, Bertoni F, Enneking WF 1986 Osteosarcoma of the mandible arising in fibrous dysplasia. A case report. Clin Orthop Relat Res 238-244
16. Taconis WK 1988 Osteosarcoma in fibrous dysplasia. Skeletal Radiol 17:163-170
17. Heller AJ, DiNardo LJ, Massey D 2001 Fibrous dysplasia, chondrosarcoma, and McCune-Albright syndrome. Am J Otolaryngol 22:297-301
18. Kaushik S, Smoker WR, Frable WJ 2002 Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma. Skeletal Radiol 31:103-106
19. Jhala DN, Eltoum I, Carroll AJ, Lopez-Ben R, Lopez-Terrada D, Rao PH, Pettenati MJ, Siegal GP 2003 Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol 34:1354-1357
20. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ 2000 Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171-1177